The Abbreviated Impactor Measurement (AIM) Concept: Part 1—Influence of Particle Bounce and Re-Entrainment—Evaluation with a “Dry” Pressurized Metered Dose Inhaler (pMDI)-Based Formulation

The abbreviated impactor measurement concept is a potential improvement to the labor-intensive full-resolution cascade impactor methodology for inhaler aerosol aerodynamic particle size distribution (APSD) measurement by virtue of being simpler and therefore quicker to execute. At the same time, improved measurement precision should be possible by eliminating stages upon which little or no drug mass is collected. Although several designs of abbreviated impactor systems have been developed in recent years, experimental work is lacking to validate the technique with aerosols produced by currently available inhalers. In part 1 of this two-part article that focuses on aerosols produced by pressurized metered dose inhalers (pMDIs), the evaluation of two abbreviated impactor systems (Copley fast screening Andersen impactor and Trudell fast screening Andersen impactor), based on the full-resolution eight-stage Andersen nonviable cascade impactor (ACI) operating principle, is reported with a formulation producing dry particles. The purpose was to investigate the potential for non-ideal collection behavior associated with particle bounce in relation to internal losses to surfaces from which particles containing active pharmaceutical ingredient are not normally recovered. Both abbreviated impactors were found to be substantially equivalent to the full-resolution ACI in terms of extra-fine and fine particle and coarse mass fractions used as metrics to characterize the APSD of these pMDI-produced aerosols when sampled at 28.3 L/min, provided that precautions are taken to coat collection plates to minimize bounce and entrainment.

[1]  J. Gaddum,et al.  United States Pharmacopeia , 1955, Nature.

[2]  Svetlana Lyapustina,et al.  Product quality research institute evaluation of cascade impactor profiles of pharmaceutical aerosols, part 3: Final report on a statistical procedure for determining equivalence , 2008, AAPS PharmSciTech.

[3]  G. Rudolf,et al.  Modelling and algebraic formulation of regional aerosol deposition in man , 1990 .

[4]  Nicholas C. Miller,et al.  Effect of Drug Load and Plate Coating on the Particle Size Distribution of a Commercial Albuterol Metered Dose Inhaler (MDI) Determined Using the Andersen and Marple-Miller Cascade Impactors , 1997, Pharmaceutical Research.

[5]  Magnus Svartengren,et al.  Basic Principles of Particle Behavior in the Human Respiratory Tract , 2001 .

[6]  Ahmad Husseini,et al.  Canadian standards association , 1993 .

[7]  Dieter Hochrainer,et al.  Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: Design. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[8]  D. Lawson,et al.  Characteristics of cascade impactors in size determination of diesel particles , 1981 .

[9]  Gerald C. Smaldone,et al.  Drug Delivery to the Lung , 2001 .

[10]  Daryl L Roberts,et al.  Relationship of stage mensuration data to the performance of new and used cascade impactors. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[11]  B A Olson,et al.  The role of inertial particle collectors in evaluating pharmaceutical aerosol delivery systems. , 1998, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[12]  Michael Hindle,et al.  Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods. , 2004, Journal of pharmaceutical sciences.

[13]  M. Dolovich,et al.  Canadian Standards Association standard CAN/CSA/Z264.1-02:2002: a new voluntary standard for spacers and holding chambers used with pressurized metered-dose inhalers. , 2004, Canadian respiratory journal.

[14]  Svetlana Lyapustina,et al.  Considerations for the development and practice of cascade impaction testing, including a mass balance failure investigation tree. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[15]  N. P. Vaughan,et al.  The Andersen impactor: Calibration, wall losses and numerical simulation , 1989 .

[16]  C. Quale,et al.  Minimizing Variability of Cascade Impaction Measurements in Inhalers and Nebulizers , 2008, AAPS PharmSciTech.

[17]  J. Mitchell,et al.  An assessment of an andersen mark-II cascade impactor , 1988 .

[18]  Jolyon P Mitchell,et al.  Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[19]  Jolyon Mitchell,et al.  Analysis of cascade impactor mass distributions. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[20]  R. Woodhouse,et al.  Pharmaceutical transition to non-CFC pressurized metered dose inhalers. , 2000, Respiratory medicine.